Correlation Between RenovoRx and Edesa Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Edesa Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Edesa Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Edesa Biotech, you can compare the effects of market volatilities on RenovoRx and Edesa Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Edesa Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Edesa Biotech.

Diversification Opportunities for RenovoRx and Edesa Biotech

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between RenovoRx and Edesa is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Edesa Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edesa Biotech and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Edesa Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edesa Biotech has no effect on the direction of RenovoRx i.e., RenovoRx and Edesa Biotech go up and down completely randomly.

Pair Corralation between RenovoRx and Edesa Biotech

Given the investment horizon of 90 days RenovoRx is expected to generate 1.84 times more return on investment than Edesa Biotech. However, RenovoRx is 1.84 times more volatile than Edesa Biotech. It trades about 0.07 of its potential returns per unit of risk. Edesa Biotech is currently generating about -0.02 per unit of risk. If you would invest  64.00  in RenovoRx on August 26, 2024 and sell it today you would earn a total of  65.00  from holding RenovoRx or generate 101.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

RenovoRx  vs.  Edesa Biotech

 Performance 
       Timeline  
RenovoRx 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.
Edesa Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Edesa Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

RenovoRx and Edesa Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RenovoRx and Edesa Biotech

The main advantage of trading using opposite RenovoRx and Edesa Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Edesa Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edesa Biotech will offset losses from the drop in Edesa Biotech's long position.
The idea behind RenovoRx and Edesa Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings